Olga Pasternak-Wise to Adult
This is a "connection" page, showing publications Olga Pasternak-Wise has written about Adult.
Connection Strength
0.015
-
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jul 01; 10(7):923-931.
Score: 0.015